Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 1
2000 5
2001 4
2002 5
2003 6
2004 5
2005 4
2006 1
2007 2
2008 7
2009 4
2010 8
2011 8
2012 9
2013 9
2014 3
2015 1
2016 3
2017 7
2018 7
2019 4
2020 10
2021 10
2022 9
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
El Taha L, Abu Musa A, Khalifeh D, Khalil A, Abbasi S, Nassif J. El Taha L, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:205-212. doi: 10.1016/j.ejogrb.2021.10.029. Epub 2021 Oct 30. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34826668 Clinical Trial.
OBJECTIVE: To compare the efficacy of dienogest with the combined oral contraceptive pill (COC) Yasmin for the control of endometriosis-associated pelvic pain. ...Nevertheless, dienogest was associated with fewer side-effects, and hence had a better safety and toler …
OBJECTIVE: To compare the efficacy of dienogest with the combined oral contraceptive pill (COC) Yasmin for the control of endometrios …
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis.
Muzii L, Di Tucci C, Galati G, Carbone F, Palaia I, Bogani G, Perniola G, Tomao F, Kontopantelis E, Di Donato V. Muzii L, et al. Reprod Sci. 2023 Nov;30(11):3135-3143. doi: 10.1007/s43032-023-01266-0. Epub 2023 May 22. Reprod Sci. 2023. PMID: 37217824 Free PMC article. Review.
In the secondary analysis, a trend toward reduction of pain at 6 months was reported in patients treated with dienogest over placebo, with each study reporting a significantly higher reduction of pain after dienogest treatment. ...Dienogest is superior to pla …
In the secondary analysis, a trend toward reduction of pain at 6 months was reported in patients treated with dienogest over placebo, …
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
Ceccaroni M, Clarizia R, Liverani S, Donati A, Ceccarello M, Manzone M, Roviglione G, Ferrero S. Ceccaroni M, et al. Gynecol Endocrinol. 2021 Oct;37(10):930-933. doi: 10.1080/09513590.2021.1929151. Epub 2021 May 26. Gynecol Endocrinol. 2021. PMID: 34036845 Clinical Trial.

RESULTS: Both Dienogest and GnRH agonists were associated with a highly significant reduction of pain at 6 and 30 months, without any significant difference (p < .001). ...CONCLUSIONS: Dienogest has proven to be as effective as GnRH agonists in preventing recurre

RESULTS: Both Dienogest and GnRH agonists were associated with a highly significant reduction of pain at 6 and 30 months, without any …
Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Guo W, Lin Y, Hu S, Shen Y. Guo W, et al. Clin Ther. 2023 Oct;45(10):973-976. doi: 10.1016/j.clinthera.2023.07.019. Epub 2023 Aug 18. Clin Ther. 2023. PMID: 37599165 Clinical Trial.
PURPOSE: The goal of this study was to examine the efficacy and safety of the levonorgestrel intrauterine system (LNG-IUS) versus dienogest (DNG) in female subjects with symptomatic uterine adenomyosis. ...
PURPOSE: The goal of this study was to examine the efficacy and safety of the levonorgestrel intrauterine system (LNG-IUS) versus dienoge
[Dienogest usefulness in pelvic pain due to endometriosis. A meta-analysis of its effectiveness].
García Uranga-Romano J, Hernández-Valencia M, Zárate A, Basavilvazo-Rodríguez MA. García Uranga-Romano J, et al. Rev Med Inst Mex Seguro Soc. 2017 Jul-Aug;55(4):452-455. Rev Med Inst Mex Seguro Soc. 2017. PMID: 28591499 Review. Spanish.
The objective of this study was to evaluate the effectiveness of dienogest in patients with pelvic pain associated to endometriosis (PPAE). ...CONCLUSION: Compared to danazol, medroxiprogesterone and gosereline, dienogest is the most efficient alternative to treat P …
The objective of this study was to evaluate the effectiveness of dienogest in patients with pelvic pain associated to endometriosis ( …
Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis.
Wu H, Liu JJ, Ye ST, Liu J, Li N. Wu H, et al. Eur J Obstet Gynecol Reprod Biol. 2024 Jun;297:40-49. doi: 10.1016/j.ejogrb.2024.03.032. Epub 2024 Mar 27. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38579545 Review.
OBJECTIVE: To systematically review and conduct a meta-analysis to assess the effectiveness of dienogest (DNG) in the prolonged conservative drug management of deep infiltrating endometriosis (DIE). ...
OBJECTIVE: To systematically review and conduct a meta-analysis to assess the effectiveness of dienogest (DNG) in the prolonged conse …
Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis.
Shao W, Li Y, Wang Y. Shao W, et al. J Ovarian Res. 2023 Aug 16;16(1):166. doi: 10.1186/s13048-023-01245-8. J Ovarian Res. 2023. PMID: 37587520 Free PMC article.
BACKGROUND: To comprehensively evaluate the influence of dienogest (DNG) versus non-DNG pretreatment on in vitro fertilization and embryo transfer (IVF-ET) outcomes for patients with endometriosis. ...
BACKGROUND: To comprehensively evaluate the influence of dienogest (DNG) versus non-DNG pretreatment on in vitro fertilization and em …
The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis.
Ali MK, Hussein RS, Abdallah KS, Mohamed AA. Ali MK, et al. J Gynecol Obstet Hum Reprod. 2024 Sep;53(7):102795. doi: 10.1016/j.jogoh.2024.102795. Epub 2024 May 8. J Gynecol Obstet Hum Reprod. 2024. PMID: 38729430 Review.
This systematic review and meta-analysis investigated the role of dienogest, an oral progestin, in reducing pain and bleeding associated with adenomyosis. ...One comparison was performed comparing outcomes in symptomatic adenomyosis before and after treatment with dieno
This systematic review and meta-analysis investigated the role of dienogest, an oral progestin, in reducing pain and bleeding associa …
The Effects of Long-Term Dienogest Therapy on In Vitro Fertilization Outcomes in Women with Endometriosis: A Systematic Review and Meta-Analysis.
Reiter A, Balayla J, Dahdouh EM, Awwad JT. Reiter A, et al. J Obstet Gynaecol Can. 2024 Apr;46(4):102339. doi: 10.1016/j.jogc.2023.102339. Epub 2024 Jan 2. J Obstet Gynaecol Can. 2024. PMID: 38176680 Review.
OBJECTIVES: Assessing dienogest's efficacy in endometriosis patients undergoing in vitro fertilization (IVF). ...Given limited data and very low evidence quality, doubts arise about the benefits of long-term dienogest pre-treatment before conventional IVF in endomet …
OBJECTIVES: Assessing dienogest's efficacy in endometriosis patients undergoing in vitro fertilization (IVF). ...Given limited data a …
Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study.
Yu Q, Zhang S, Li H, Wang P, Zvolanek M, Ren X, Dong L, Lang J. Yu Q, et al. J Womens Health (Larchmt). 2019 Feb;28(2):170-177. doi: 10.1089/jwh.2018.7084. Epub 2018 Nov 21. J Womens Health (Larchmt). 2019. PMID: 30461337 Clinical Trial.
At the end of open-label study, mean (SD) change from baseline in EAPP score on VAS was -43.1 mm (26.54 mm) and -39.8 mm (31.15 mm) in the prior-dienogest and prior-placebo groups, respectively. Other assessments confirmed that dienogest maintained or enhanced effic …
At the end of open-label study, mean (SD) change from baseline in EAPP score on VAS was -43.1 mm (26.54 mm) and -39.8 mm (31.15 mm) in the p …
137 results